nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentermine—CYP1A2—urine—urinary bladder cancer	0.0163	0.12	CbGeAlD
Phentermine—CYP2C9—urine—urinary bladder cancer	0.0154	0.114	CbGeAlD
Phentermine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0145	0.252	CbGbCtD
Phentermine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0131	0.227	CbGbCtD
Phentermine—CYP1A2—Etoposide—urinary bladder cancer	0.0121	0.21	CbGbCtD
Phentermine—CYP2D6—urine—urinary bladder cancer	0.0116	0.0852	CbGeAlD
Phentermine—CYP2C9—Cisplatin—urinary bladder cancer	0.0111	0.193	CbGbCtD
Phentermine—Pseudoephedrine—IL2—urinary bladder cancer	0.00917	0.748	CrCbGaD
Phentermine—Dyspnoea exertional—Epirubicin—urinary bladder cancer	0.00857	0.0247	CcSEcCtD
Phentermine—MAOB—prostate gland—urinary bladder cancer	0.0082	0.0603	CbGeAlD
Phentermine—Dyspnoea exertional—Doxorubicin—urinary bladder cancer	0.00793	0.0228	CcSEcCtD
Phentermine—MAOA—prostate gland—urinary bladder cancer	0.00699	0.0515	CbGeAlD
Phentermine—MAOB—seminal vesicle—urinary bladder cancer	0.00693	0.051	CbGeAlD
Phentermine—Chest pain—Valrubicin—urinary bladder cancer	0.00691	0.0199	CcSEcCtD
Phentermine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0068	0.118	CbGbCtD
Phentermine—MAOA—seminal vesicle—urinary bladder cancer	0.00591	0.0435	CbGeAlD
Phentermine—MAOB—renal system—urinary bladder cancer	0.00559	0.0411	CbGeAlD
Phentermine—MAOB—urethra—urinary bladder cancer	0.00549	0.0404	CbGeAlD
Phentermine—Abdominal pain—Valrubicin—urinary bladder cancer	0.00523	0.0151	CcSEcCtD
Phentermine—Hypertension—Mitomycin—urinary bladder cancer	0.00483	0.0139	CcSEcCtD
Phentermine—Cardiac failure—Thiotepa—urinary bladder cancer	0.00478	0.0138	CcSEcCtD
Phentermine—MAOA—renal system—urinary bladder cancer	0.00477	0.0351	CbGeAlD
Phentermine—Asthenia—Valrubicin—urinary bladder cancer	0.00475	0.0137	CcSEcCtD
Phentermine—SLC6A4—female reproductive system—urinary bladder cancer	0.00471	0.0346	CbGeAlD
Phentermine—MAOA—urethra—urinary bladder cancer	0.00468	0.0345	CbGeAlD
Phentermine—Euphoric mood—Fluorouracil—urinary bladder cancer	0.00457	0.0132	CcSEcCtD
Phentermine—Oedema—Mitomycin—urinary bladder cancer	0.00456	0.0131	CcSEcCtD
Phentermine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00453	0.013	CcSEcCtD
Phentermine—MAOB—female reproductive system—urinary bladder cancer	0.00447	0.0329	CbGeAlD
Phentermine—Cardiac arrest—Thiotepa—urinary bladder cancer	0.00444	0.0128	CcSEcCtD
Phentermine—Dizziness—Valrubicin—urinary bladder cancer	0.00438	0.0126	CcSEcCtD
Phentermine—Vomiting—Valrubicin—urinary bladder cancer	0.00421	0.0121	CcSEcCtD
Phentermine—Rash—Valrubicin—urinary bladder cancer	0.00417	0.012	CcSEcCtD
Phentermine—Dermatitis—Valrubicin—urinary bladder cancer	0.00417	0.012	CcSEcCtD
Phentermine—Headache—Valrubicin—urinary bladder cancer	0.00415	0.0119	CcSEcCtD
Phentermine—SLC6A2—female reproductive system—urinary bladder cancer	0.00414	0.0305	CbGeAlD
Phentermine—MAOB—vagina—urinary bladder cancer	0.00405	0.0298	CbGeAlD
Phentermine—Cardiac failure—Gemcitabine—urinary bladder cancer	0.00402	0.0116	CcSEcCtD
Phentermine—Cerebrovascular accident—Gemcitabine—urinary bladder cancer	0.00401	0.0115	CcSEcCtD
Phentermine—CYP1A2—renal system—urinary bladder cancer	0.00398	0.0293	CbGeAlD
Phentermine—Cardiac failure—Fluorouracil—urinary bladder cancer	0.00396	0.0114	CcSEcCtD
Phentermine—Nausea—Valrubicin—urinary bladder cancer	0.00393	0.0113	CcSEcCtD
Phentermine—Fatigue—Mitomycin—urinary bladder cancer	0.00393	0.0113	CcSEcCtD
Phentermine—MAOA—female reproductive system—urinary bladder cancer	0.00382	0.0281	CbGeAlD
Phentermine—Cerebrovascular accident—Cisplatin—urinary bladder cancer	0.00373	0.0108	CcSEcCtD
Phentermine—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.00367	0.0106	CcSEcCtD
Phentermine—MAOA—vagina—urinary bladder cancer	0.00345	0.0254	CbGeAlD
Phentermine—Cardiac failure—Etoposide—urinary bladder cancer	0.00344	0.00989	CcSEcCtD
Phentermine—Asthenia—Mitomycin—urinary bladder cancer	0.00327	0.00942	CcSEcCtD
Phentermine—Angina pectoris—Fluorouracil—urinary bladder cancer	0.00325	0.00936	CcSEcCtD
Phentermine—Hallucination—Thiotepa—urinary bladder cancer	0.00321	0.00925	CcSEcCtD
Phentermine—Cardiac arrest—Etoposide—urinary bladder cancer	0.00319	0.00918	CcSEcCtD
Phentermine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00312	0.00899	CcSEcCtD
Phentermine—Pseudoephedrine—TNF—urinary bladder cancer	0.0031	0.252	CrCbGaD
Phentermine—CYP2C9—female reproductive system—urinary bladder cancer	0.00302	0.0223	CbGeAlD
Phentermine—Dizziness—Mitomycin—urinary bladder cancer	0.00302	0.00868	CcSEcCtD
Phentermine—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.00298	0.00859	CcSEcCtD
Phentermine—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.00297	0.00854	CcSEcCtD
Phentermine—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.00293	0.00844	CcSEcCtD
Phentermine—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.00292	0.0084	CcSEcCtD
Phentermine—Vomiting—Mitomycin—urinary bladder cancer	0.0029	0.00835	CcSEcCtD
Phentermine—Rash—Mitomycin—urinary bladder cancer	0.00288	0.00828	CcSEcCtD
Phentermine—Dermatitis—Mitomycin—urinary bladder cancer	0.00287	0.00827	CcSEcCtD
Phentermine—Headache—Mitomycin—urinary bladder cancer	0.00286	0.00823	CcSEcCtD
Phentermine—CYP2D6—renal system—urinary bladder cancer	0.00283	0.0209	CbGeAlD
Phentermine—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.00278	0.008	CcSEcCtD
Phentermine—Myocardial infarction—Cisplatin—urinary bladder cancer	0.00276	0.00796	CcSEcCtD
Phentermine—Tension—Thiotepa—urinary bladder cancer	0.00276	0.00794	CcSEcCtD
Phentermine—Nervousness—Thiotepa—urinary bladder cancer	0.00273	0.00786	CcSEcCtD
Phentermine—Nausea—Mitomycin—urinary bladder cancer	0.00271	0.0078	CcSEcCtD
Phentermine—MAOB—lymph node—urinary bladder cancer	0.00262	0.0193	CbGeAlD
Phentermine—Agitation—Thiotepa—urinary bladder cancer	0.00258	0.00744	CcSEcCtD
Phentermine—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.00255	0.00733	CcSEcCtD
Phentermine—Myocardial infarction—Etoposide—urinary bladder cancer	0.00253	0.00729	CcSEcCtD
Phentermine—Hypertension—Thiotepa—urinary bladder cancer	0.00243	0.00699	CcSEcCtD
Phentermine—SLC6A2—lymph node—urinary bladder cancer	0.00242	0.0178	CbGeAlD
Phentermine—CYP2D6—female reproductive system—urinary bladder cancer	0.00227	0.0167	CbGeAlD
Phentermine—Tachycardia—Thiotepa—urinary bladder cancer	0.00224	0.00645	CcSEcCtD
Phentermine—MAOA—lymph node—urinary bladder cancer	0.00223	0.0164	CbGeAlD
Phentermine—Tremor—Cisplatin—urinary bladder cancer	0.00206	0.00594	CcSEcCtD
Phentermine—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.00205	0.0059	CcSEcCtD
Phentermine—Hypertension—Gemcitabine—urinary bladder cancer	0.00204	0.00588	CcSEcCtD
Phentermine—Dyspepsia—Thiotepa—urinary bladder cancer	0.00202	0.00581	CcSEcCtD
Phentermine—Chest pain—Gemcitabine—urinary bladder cancer	0.00201	0.0058	CcSEcCtD
Phentermine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00198	0.0057	CcSEcCtD
Phentermine—Chest pain—Fluorouracil—urinary bladder cancer	0.00198	0.0057	CcSEcCtD
Phentermine—Fatigue—Thiotepa—urinary bladder cancer	0.00198	0.00569	CcSEcCtD
Phentermine—Constipation—Thiotepa—urinary bladder cancer	0.00196	0.00565	CcSEcCtD
Phentermine—Oedema—Gemcitabine—urinary bladder cancer	0.00193	0.00556	CcSEcCtD
Phentermine—Cardiac failure—Epirubicin—urinary bladder cancer	0.00193	0.00554	CcSEcCtD
Phentermine—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.00192	0.00552	CcSEcCtD
Phentermine—Oedema—Fluorouracil—urinary bladder cancer	0.0019	0.00546	CcSEcCtD
Phentermine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00185	0.00533	CcSEcCtD
Phentermine—Urticaria—Thiotepa—urinary bladder cancer	0.00182	0.00525	CcSEcCtD
Phentermine—Abdominal pain—Thiotepa—urinary bladder cancer	0.00181	0.00522	CcSEcCtD
Phentermine—Oedema—Cisplatin—urinary bladder cancer	0.0018	0.00518	CcSEcCtD
Phentermine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00179	0.00514	CcSEcCtD
Phentermine—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00178	0.00513	CcSEcCtD
Phentermine—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.00177	0.00511	CcSEcCtD
Phentermine—Tachycardia—Cisplatin—urinary bladder cancer	0.00176	0.00505	CcSEcCtD
Phentermine—Insomnia—Gemcitabine—urinary bladder cancer	0.00175	0.00502	CcSEcCtD
Phentermine—Hypertension—Etoposide—urinary bladder cancer	0.00174	0.00502	CcSEcCtD
Phentermine—Chest pain—Etoposide—urinary bladder cancer	0.00172	0.00495	CcSEcCtD
Phentermine—Insomnia—Fluorouracil—urinary bladder cancer	0.00172	0.00494	CcSEcCtD
Phentermine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00167	0.00481	CcSEcCtD
Phentermine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00167	0.0048	CcSEcCtD
Phentermine—Fatigue—Gemcitabine—urinary bladder cancer	0.00166	0.00479	CcSEcCtD
Phentermine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00165	0.00476	CcSEcCtD
Phentermine—Constipation—Gemcitabine—urinary bladder cancer	0.00165	0.00475	CcSEcCtD
Phentermine—Asthenia—Thiotepa—urinary bladder cancer	0.00165	0.00474	CcSEcCtD
Phentermine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00164	0.00472	CcSEcCtD
Phentermine—Tachycardia—Etoposide—urinary bladder cancer	0.00161	0.00463	CcSEcCtD
Phentermine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.0016	0.0046	CcSEcCtD
Phentermine—Angina pectoris—Epirubicin—urinary bladder cancer	0.00158	0.00456	CcSEcCtD
Phentermine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00157	0.00452	CcSEcCtD
Phentermine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00155	0.00447	CcSEcCtD
Phentermine—Dizziness—Thiotepa—urinary bladder cancer	0.00152	0.00437	CcSEcCtD
Phentermine—Urticaria—Fluorouracil—urinary bladder cancer	0.00151	0.00434	CcSEcCtD
Phentermine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00146	0.00421	CcSEcCtD
Phentermine—Vomiting—Thiotepa—urinary bladder cancer	0.00146	0.0042	CcSEcCtD
Phentermine—Rash—Thiotepa—urinary bladder cancer	0.00145	0.00416	CcSEcCtD
Phentermine—Dermatitis—Thiotepa—urinary bladder cancer	0.00145	0.00416	CcSEcCtD
Phentermine—Headache—Thiotepa—urinary bladder cancer	0.00144	0.00414	CcSEcCtD
Phentermine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00142	0.0041	CcSEcCtD
Phentermine—Fatigue—Etoposide—urinary bladder cancer	0.00142	0.00409	CcSEcCtD
Phentermine—Constipation—Etoposide—urinary bladder cancer	0.00141	0.00406	CcSEcCtD
Phentermine—Asthenia—Gemcitabine—urinary bladder cancer	0.00138	0.00399	CcSEcCtD
Phentermine—Nausea—Thiotepa—urinary bladder cancer	0.00136	0.00392	CcSEcCtD
Phentermine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00132	0.0038	CcSEcCtD
Phentermine—Urticaria—Etoposide—urinary bladder cancer	0.00131	0.00377	CcSEcCtD
Phentermine—Abdominal pain—Etoposide—urinary bladder cancer	0.0013	0.00375	CcSEcCtD
Phentermine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.0013	0.00374	CcSEcCtD
Phentermine—Asthenia—Cisplatin—urinary bladder cancer	0.00129	0.00372	CcSEcCtD
Phentermine—Dizziness—Fluorouracil—urinary bladder cancer	0.00125	0.00361	CcSEcCtD
Phentermine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00123	0.00354	CcSEcCtD
Phentermine—Vomiting—Gemcitabine—urinary bladder cancer	0.00123	0.00353	CcSEcCtD
Phentermine—Rash—Gemcitabine—urinary bladder cancer	0.00122	0.0035	CcSEcCtD
Phentermine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00122	0.0035	CcSEcCtD
Phentermine—Headache—Gemcitabine—urinary bladder cancer	0.00121	0.00348	CcSEcCtD
Phentermine—Vomiting—Fluorouracil—urinary bladder cancer	0.00121	0.00347	CcSEcCtD
Phentermine—SLC6A4—NRF2 pathway—GSTM1—urinary bladder cancer	0.0012	0.00269	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—NQO1—urinary bladder cancer	0.0012	0.00268	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.0012	0.00268	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.0012	0.00268	CbGpPWpGaD
Phentermine—Rash—Fluorouracil—urinary bladder cancer	0.0012	0.00344	CcSEcCtD
Phentermine—Dermatitis—Fluorouracil—urinary bladder cancer	0.0012	0.00344	CcSEcCtD
Phentermine—Headache—Fluorouracil—urinary bladder cancer	0.00119	0.00342	CcSEcCtD
Phentermine—Asthenia—Etoposide—urinary bladder cancer	0.00118	0.0034	CcSEcCtD
Phentermine—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.00118	0.00264	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.00118	0.00264	CbGpPWpGaD
Phentermine—SLC6A3—Monoamine Transport—TNF—urinary bladder cancer	0.00118	0.00263	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00116	0.0026	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.00115	0.00257	CbGpPWpGaD
Phentermine—Nausea—Gemcitabine—urinary bladder cancer	0.00115	0.0033	CcSEcCtD
Phentermine—Vomiting—Cisplatin—urinary bladder cancer	0.00114	0.00329	CcSEcCtD
Phentermine—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.00114	0.00254	CbGpPWpGaD
Phentermine—Rash—Cisplatin—urinary bladder cancer	0.00113	0.00327	CcSEcCtD
Phentermine—Dermatitis—Cisplatin—urinary bladder cancer	0.00113	0.00326	CcSEcCtD
Phentermine—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00113	0.00253	CbGpPWpGaD
Phentermine—Diarrhoea—Etoposide—urinary bladder cancer	0.00113	0.00325	CcSEcCtD
Phentermine—SLC6A2—NRF2 pathway—GSTP1—urinary bladder cancer	0.00113	0.00252	CbGpPWpGaD
Phentermine—Nausea—Fluorouracil—urinary bladder cancer	0.00113	0.00324	CcSEcCtD
Phentermine—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00112	0.00251	CbGpPWpGaD
Phentermine—Tension—Epirubicin—urinary bladder cancer	0.00111	0.0032	CcSEcCtD
Phentermine—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.00111	0.00247	CbGpPWpGaD
Phentermine—Nervousness—Epirubicin—urinary bladder cancer	0.0011	0.00316	CcSEcCtD
Phentermine—Dizziness—Etoposide—urinary bladder cancer	0.00109	0.00314	CcSEcCtD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00109	0.00243	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.00108	0.00241	CbGpPWpGaD
Phentermine—Nausea—Cisplatin—urinary bladder cancer	0.00107	0.00308	CcSEcCtD
Phentermine—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00106	0.00238	CbGpPWpGaD
Phentermine—Vomiting—Etoposide—urinary bladder cancer	0.00105	0.00302	CcSEcCtD
Phentermine—Agitation—Epirubicin—urinary bladder cancer	0.00104	0.00299	CcSEcCtD
Phentermine—Rash—Etoposide—urinary bladder cancer	0.00104	0.00299	CcSEcCtD
Phentermine—Dermatitis—Etoposide—urinary bladder cancer	0.00104	0.00299	CcSEcCtD
Phentermine—SLC6A2—NRF2 pathway—GSTM1—urinary bladder cancer	0.00104	0.00232	CbGpPWpGaD
Phentermine—Headache—Etoposide—urinary bladder cancer	0.00103	0.00297	CcSEcCtD
Phentermine—Chest pain—Methotrexate—urinary bladder cancer	0.00103	0.00296	CcSEcCtD
Phentermine—Tension—Doxorubicin—urinary bladder cancer	0.00103	0.00296	CcSEcCtD
Phentermine—Nervousness—Doxorubicin—urinary bladder cancer	0.00102	0.00293	CcSEcCtD
Phentermine—Palpitations—Epirubicin—urinary bladder cancer	0.001	0.00288	CcSEcCtD
Phentermine—SLC6A3—NRF2 pathway—GSTP1—urinary bladder cancer	0.000999	0.00223	CbGpPWpGaD
Phentermine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00098	0.00219	CbGpPWpGaD
Phentermine—Nausea—Etoposide—urinary bladder cancer	0.000979	0.00282	CcSEcCtD
Phentermine—Hypertension—Epirubicin—urinary bladder cancer	0.000977	0.00281	CcSEcCtD
Phentermine—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.000972	0.00217	CbGpPWpGaD
Phentermine—Chest pain—Epirubicin—urinary bladder cancer	0.000964	0.00277	CcSEcCtD
Phentermine—Agitation—Doxorubicin—urinary bladder cancer	0.000962	0.00277	CcSEcCtD
Phentermine—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000962	0.00215	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000959	0.00214	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000944	0.00211	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—GSTP1—urinary bladder cancer	0.000942	0.00211	CbGpPWpGaD
Phentermine—Dry mouth—Epirubicin—urinary bladder cancer	0.000942	0.00271	CcSEcCtD
Phentermine—SLC6A4—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000933	0.00209	CbGpPWpGaD
Phentermine—Palpitations—Doxorubicin—urinary bladder cancer	0.000925	0.00266	CcSEcCtD
Phentermine—Oedema—Epirubicin—urinary bladder cancer	0.000924	0.00266	CcSEcCtD
Phentermine—MAOB—Metabolism—GSTZ1—urinary bladder cancer	0.00092	0.00206	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—GSTM1—urinary bladder cancer	0.000918	0.00205	CbGpPWpGaD
Phentermine—Hypertension—Doxorubicin—urinary bladder cancer	0.000904	0.0026	CcSEcCtD
Phentermine—Tachycardia—Epirubicin—urinary bladder cancer	0.000901	0.0026	CcSEcCtD
Phentermine—Insomnia—Methotrexate—urinary bladder cancer	0.000893	0.00257	CcSEcCtD
Phentermine—Chest pain—Doxorubicin—urinary bladder cancer	0.000892	0.00257	CcSEcCtD
Phentermine—SLC6A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000886	0.00198	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.000884	0.00198	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTO2—urinary bladder cancer	0.000872	0.00195	CbGpPWpGaD
Phentermine—MAOB—Metabolism—NAT1—urinary bladder cancer	0.000872	0.00195	CbGpPWpGaD
Phentermine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000872	0.00251	CcSEcCtD
Phentermine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000869	0.0025	CcSEcCtD
Phentermine—MAOA—Biological oxidations—GSTM1—urinary bladder cancer	0.000866	0.00194	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000857	0.00192	CbGpPWpGaD
Phentermine—Oedema—Doxorubicin—urinary bladder cancer	0.000855	0.00246	CcSEcCtD
Phentermine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000852	0.00245	CcSEcCtD
Phentermine—Fatigue—Methotrexate—urinary bladder cancer	0.000851	0.00245	CcSEcCtD
Phentermine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000837	0.00187	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—FAS—urinary bladder cancer	0.000836	0.00187	CbGpPWpGaD
Phentermine—Insomnia—Epirubicin—urinary bladder cancer	0.000835	0.00241	CcSEcCtD
Phentermine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000834	0.0024	CcSEcCtD
Phentermine—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000822	0.00184	CbGpPWpGaD
Phentermine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000813	0.00234	CcSEcCtD
Phentermine—MAOB—Metabolism—UGT2B7—urinary bladder cancer	0.000798	0.00178	CbGpPWpGaD
Phentermine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000797	0.0023	CcSEcCtD
Phentermine—Fatigue—Epirubicin—urinary bladder cancer	0.000796	0.00229	CcSEcCtD
Phentermine—Constipation—Epirubicin—urinary bladder cancer	0.00079	0.00227	CcSEcCtD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000787	0.00176	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000785	0.00176	CbGpPWpGaD
Phentermine—Urticaria—Methotrexate—urinary bladder cancer	0.000784	0.00226	CcSEcCtD
Phentermine—Abdominal pain—Methotrexate—urinary bladder cancer	0.00078	0.00225	CcSEcCtD
Phentermine—Insomnia—Doxorubicin—urinary bladder cancer	0.000773	0.00223	CcSEcCtD
Phentermine—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.000763	0.00171	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000757	0.00169	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000753	0.00168	CbGpPWpGaD
Phentermine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000752	0.00217	CcSEcCtD
Phentermine—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000746	0.00167	CbGpPWpGaD
Phentermine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000738	0.00212	CcSEcCtD
Phentermine—Fatigue—Doxorubicin—urinary bladder cancer	0.000737	0.00212	CcSEcCtD
Phentermine—SLC6A4—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000736	0.00165	CbGpPWpGaD
Phentermine—Urticaria—Epirubicin—urinary bladder cancer	0.000734	0.00211	CcSEcCtD
Phentermine—Constipation—Doxorubicin—urinary bladder cancer	0.000731	0.0021	CcSEcCtD
Phentermine—Abdominal pain—Epirubicin—urinary bladder cancer	0.00073	0.0021	CcSEcCtD
Phentermine—SLC6A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000723	0.00162	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000721	0.00161	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYP4B1—urinary bladder cancer	0.000718	0.00161	CbGpPWpGaD
Phentermine—Asthenia—Methotrexate—urinary bladder cancer	0.000708	0.00204	CcSEcCtD
Phentermine—Urticaria—Doxorubicin—urinary bladder cancer	0.000679	0.00195	CcSEcCtD
Phentermine—MAOB—Metabolism—SLC19A1—urinary bladder cancer	0.000678	0.00152	CbGpPWpGaD
Phentermine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000676	0.00195	CcSEcCtD
Phentermine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000675	0.00194	CcSEcCtD
Phentermine—SLC6A4—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000669	0.0015	CbGpPWpGaD
Phentermine—Asthenia—Epirubicin—urinary bladder cancer	0.000663	0.00191	CcSEcCtD
Phentermine—MAOB—Metabolism—PRSS3—urinary bladder cancer	0.000661	0.00148	CbGpPWpGaD
Phentermine—Dizziness—Methotrexate—urinary bladder cancer	0.000653	0.00188	CcSEcCtD
Phentermine—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000647	0.00145	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000645	0.00144	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00064	0.00143	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000638	0.00143	CbGpPWpGaD
Phentermine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000632	0.00182	CcSEcCtD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000629	0.00141	CbGpPWpGaD
Phentermine—Vomiting—Methotrexate—urinary bladder cancer	0.000628	0.00181	CcSEcCtD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000625	0.0014	CbGpPWpGaD
Phentermine—Rash—Methotrexate—urinary bladder cancer	0.000622	0.00179	CcSEcCtD
Phentermine—Dermatitis—Methotrexate—urinary bladder cancer	0.000622	0.00179	CcSEcCtD
Phentermine—Headache—Methotrexate—urinary bladder cancer	0.000618	0.00178	CcSEcCtD
Phentermine—Asthenia—Doxorubicin—urinary bladder cancer	0.000613	0.00177	CcSEcCtD
Phentermine—Dizziness—Epirubicin—urinary bladder cancer	0.000611	0.00176	CcSEcCtD
Phentermine—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.00061	0.00137	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000605	0.00135	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000594	0.00133	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000592	0.00132	CbGpPWpGaD
Phentermine—Vomiting—Epirubicin—urinary bladder cancer	0.000587	0.00169	CcSEcCtD
Phentermine—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000587	0.00131	CbGpPWpGaD
Phentermine—Nausea—Methotrexate—urinary bladder cancer	0.000586	0.00169	CcSEcCtD
Phentermine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000585	0.00168	CcSEcCtD
Phentermine—Rash—Epirubicin—urinary bladder cancer	0.000582	0.00168	CcSEcCtD
Phentermine—Dermatitis—Epirubicin—urinary bladder cancer	0.000582	0.00168	CcSEcCtD
Phentermine—Headache—Epirubicin—urinary bladder cancer	0.000579	0.00167	CcSEcCtD
Phentermine—MAOA—Metabolism—GSTZ1—urinary bladder cancer	0.000577	0.00129	CbGpPWpGaD
Phentermine—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000566	0.00127	CbGpPWpGaD
Phentermine—Dizziness—Doxorubicin—urinary bladder cancer	0.000565	0.00163	CcSEcCtD
Phentermine—Nausea—Epirubicin—urinary bladder cancer	0.000549	0.00158	CcSEcCtD
Phentermine—MAOA—Metabolism—GSTO2—urinary bladder cancer	0.000547	0.00122	CbGpPWpGaD
Phentermine—MAOA—Metabolism—NAT1—urinary bladder cancer	0.000547	0.00122	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000546	0.00122	CbGpPWpGaD
Phentermine—Vomiting—Doxorubicin—urinary bladder cancer	0.000543	0.00156	CcSEcCtD
Phentermine—Rash—Doxorubicin—urinary bladder cancer	0.000539	0.00155	CcSEcCtD
Phentermine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000538	0.00155	CcSEcCtD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000536	0.0012	CbGpPWpGaD
Phentermine—Headache—Doxorubicin—urinary bladder cancer	0.000535	0.00154	CcSEcCtD
Phentermine—MAOB—Metabolism—TYMP—urinary bladder cancer	0.000528	0.00118	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000517	0.00116	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000517	0.00116	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000512	0.00115	CbGpPWpGaD
Phentermine—Nausea—Doxorubicin—urinary bladder cancer	0.000508	0.00146	CcSEcCtD
Phentermine—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000501	0.00112	CbGpPWpGaD
Phentermine—MAOA—Metabolism—UGT2B7—urinary bladder cancer	0.000501	0.00112	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000488	0.00109	CbGpPWpGaD
Phentermine—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000484	0.00108	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000479	0.00107	CbGpPWpGaD
Phentermine—MAOB—Metabolism—NAT2—urinary bladder cancer	0.000478	0.00107	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000459	0.00103	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000452	0.00101	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYP4B1—urinary bladder cancer	0.000451	0.00101	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000439	0.000982	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—EP300—urinary bladder cancer	0.000437	0.000978	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000437	0.000977	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000435	0.000973	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000432	0.000967	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.00043	0.000962	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.00043	0.000962	CbGpPWpGaD
Phentermine—MAOA—Metabolism—SLC19A1—urinary bladder cancer	0.000426	0.000952	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000418	0.000936	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000418	0.000936	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PRSS3—urinary bladder cancer	0.000415	0.000928	CbGpPWpGaD
Phentermine—MAOB—Metabolism—RRM2—urinary bladder cancer	0.000413	0.000923	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.00041	0.000918	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000407	0.00091	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000405	0.000905	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000401	0.000897	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ENO2—urinary bladder cancer	0.000382	0.000855	CbGpPWpGaD
Phentermine—MAOB—Metabolism—HPGDS—urinary bladder cancer	0.000382	0.000855	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000377	0.000843	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000375	0.000839	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000374	0.000836	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000373	0.000835	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000372	0.000832	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTT1—urinary bladder cancer	0.000371	0.000829	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000369	0.000825	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000367	0.00082	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000367	0.00082	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000356	0.000797	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000349	0.000781	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000349	0.000781	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000348	0.000778	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000346	0.000775	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000343	0.000767	CbGpPWpGaD
Phentermine—MAOA—Metabolism—TYMP—urinary bladder cancer	0.000332	0.000742	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000319	0.000715	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000315	0.000705	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—TP53—urinary bladder cancer	0.000313	0.0007	CbGpPWpGaD
Phentermine—MAOB—Metabolism—NQO1—urinary bladder cancer	0.000308	0.000689	CbGpPWpGaD
Phentermine—MAOA—Metabolism—NAT2—urinary bladder cancer	0.0003	0.000671	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000294	0.000659	CbGpPWpGaD
Phentermine—MAOA—Metabolism—RRM2—urinary bladder cancer	0.000259	0.000579	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTP1—urinary bladder cancer	0.000257	0.000575	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000251	0.000562	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	0.000249	0.000557	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000246	0.000551	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ENO2—urinary bladder cancer	0.00024	0.000536	CbGpPWpGaD
Phentermine—MAOA—Metabolism—HPGDS—urinary bladder cancer	0.00024	0.000536	CbGpPWpGaD
Phentermine—MAOB—Metabolism—TYMS—urinary bladder cancer	0.000239	0.000534	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.000238	0.000533	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.000238	0.000533	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	0.000236	0.000528	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—NAT1—urinary bladder cancer	0.000236	0.000528	CbGpPWpGaD
Phentermine—MAOB—Metabolism—NCOR1—urinary bladder cancer	0.000236	0.000528	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTM1—urinary bladder cancer	0.000236	0.000528	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTT1—urinary bladder cancer	0.000233	0.00052	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000232	0.00052	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000229	0.000512	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000228	0.000511	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GPX1—urinary bladder cancer	0.000226	0.000506	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ERCC2—urinary bladder cancer	0.000222	0.000496	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	0.000218	0.000487	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	0.000216	0.000483	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	0.000213	0.000476	CbGpPWpGaD
Phentermine—MAOB—Metabolism—MTHFR—urinary bladder cancer	0.000209	0.000467	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000202	0.000453	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	0.000202	0.000452	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	0.000202	0.000452	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000199	0.000444	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	0.000196	0.000439	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	0.000195	0.000435	CbGpPWpGaD
Phentermine—MAOA—Metabolism—NQO1—urinary bladder cancer	0.000193	0.000432	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—HRAS—urinary bladder cancer	0.000189	0.000422	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	0.000185	0.000415	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	0.000185	0.000413	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	0.000184	0.000411	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	0.000181	0.000404	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	0.000179	0.0004	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—HRAS—urinary bladder cancer	0.000175	0.000392	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PPARG—urinary bladder cancer	0.000169	0.000378	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	0.000166	0.000372	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CREBBP—urinary bladder cancer	0.000163	0.000364	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTP1—urinary bladder cancer	0.000161	0.000361	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	0.000157	0.000351	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	0.000153	0.000342	CbGpPWpGaD
Phentermine—MAOA—Metabolism—TYMS—urinary bladder cancer	0.00015	0.000335	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTM1—urinary bladder cancer	0.000148	0.000331	CbGpPWpGaD
Phentermine—MAOA—Metabolism—NCOR1—urinary bladder cancer	0.000148	0.000331	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	0.000144	0.000323	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000144	0.000321	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	0.000143	0.00032	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GPX1—urinary bladder cancer	0.000142	0.000317	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ERCC2—urinary bladder cancer	0.000139	0.000312	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000137	0.000307	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PTGS2—urinary bladder cancer	0.000133	0.000298	CbGpPWpGaD
Phentermine—MAOA—Metabolism—MTHFR—urinary bladder cancer	0.000131	0.000293	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	0.000131	0.000292	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	0.000129	0.00029	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000123	0.000274	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	0.000122	0.000274	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000117	0.000263	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PTEN—urinary bladder cancer	0.000116	0.00026	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	0.000113	0.000252	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	0.000112	0.00025	CbGpPWpGaD
Phentermine—MAOB—Metabolism—EP300—urinary bladder cancer	0.000111	0.000248	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	0.000111	0.000247	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PPARG—urinary bladder cancer	0.000106	0.000237	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	0.000104	0.000233	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	0.000104	0.000233	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	0.000103	0.000231	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	0.000103	0.000231	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000103	0.00023	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CREBBP—urinary bladder cancer	0.000102	0.000228	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	0.000101	0.000226	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	0.0001	0.000224	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.88e-05	0.000221	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	9.55e-05	0.000214	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	8.84e-05	0.000198	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	8.84e-05	0.000198	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.79e-05	0.000197	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	8.58e-05	0.000192	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.44e-05	0.000189	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	8.41e-05	0.000188	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PTGS2—urinary bladder cancer	8.35e-05	0.000187	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	8.34e-05	0.000187	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.09e-05	0.000181	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PTEN—urinary bladder cancer	7.28e-05	0.000163	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	7.13e-05	0.000159	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.06e-05	0.000158	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	7.02e-05	0.000157	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	6.96e-05	0.000156	CbGpPWpGaD
Phentermine—MAOA—Metabolism—EP300—urinary bladder cancer	6.94e-05	0.000155	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.92e-05	0.000155	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.73e-05	0.000151	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	6.52e-05	0.000146	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	6.47e-05	0.000145	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	6.45e-05	0.000144	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	6.45e-05	0.000144	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	6.39e-05	0.000143	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	6.39e-05	0.000143	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	6.18e-05	0.000138	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	6.12e-05	0.000137	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	6.06e-05	0.000136	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.03e-05	0.000135	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	6.01e-05	0.000134	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	5.94e-05	0.000133	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.75e-05	0.000129	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	5.7e-05	0.000127	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	5.65e-05	0.000126	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	5.53e-05	0.000124	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	5.46e-05	0.000122	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	5.46e-05	0.000122	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	5.23e-05	0.000117	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	5.14e-05	0.000115	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	4.83e-05	0.000108	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	4.62e-05	0.000103	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	4.58e-05	0.000102	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	4.44e-05	9.93e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	4.4e-05	9.84e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	3.91e-05	8.76e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	3.76e-05	8.41e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	3.64e-05	8.13e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.6e-05	8.06e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.17e-05	7.09e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.14e-05	7.03e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.08e-05	6.89e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.02e-05	6.76e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—EP300—urinary bladder cancer	3e-05	6.7e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.69e-05	6.01e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.56e-05	5.73e-05	CbGpPWpGaD
